Back to search

Article

Molecular determinants of neurocognitive deficits in glioma: based on 2021 WHO classification

2023-03-17

Abstract excerpt

<h4>Purpose: </h4> Cognitive impairment is a common feature among patients with diffuse glioma. This study aimed to investigate the relationship between cognitive function and clinical and molecular factors under the new 2021 WHO classification of tumors of the central nervous system (CNS 5). Methods A total of 110 patients with diffuse glioma were enrolled and underwent preoperative cognitive assessments using t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d5437701-0a19-5c9e-a5e9-f3d68c252897
DOI
10.21203/rs.3.rs-2692224/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular determinants of neurocognitive deficits in glioma: based on 2021 WHO classificationDOI 10.21203/rs.3.rs-2692224/v1
Molecular Determinants of Neurocognitive Deficits in Glioma: Based on 2021 WHO Classification.Semantic proximity
Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumorsSemantic proximity
Opinion & Special Article: Glioma Classification: How to Interpret Molecular Markers in a Diffuse Glioma Pathology Report.Semantic proximity
miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targetsSemantic proximity
Reclassification of TCGA Diffuse Glioma Profiles Linked to Transcriptomic, Epigenetic, Genomic and Clinical Data, According to the 2021 WHO CNS Tumor Classification.Semantic proximity
Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline.Semantic proximity
WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System.Semantic proximity
Imaging-based stratification of adult gliomas prognosticates survival and correlates with the 2021 WHO classification.Semantic proximity
Imaging-Based Versus Pathologic Survival Stratifications of Diffuse Glioma According to the 2021 WHO Classification System.Semantic proximity
Individual structural MRI abnormality indexes are associated with molecular, histological and cognitive indicators for frontal glioma patientsSemantic proximity
Genomic medicine advances for brain tumors.Semantic proximity
Diffuse glioma, not otherwise specified: imaging-based risk stratification achieves histomolecular-level prognostication.Semantic proximity
Select a neighboring publication to make it the new centre.